07 APRIL 2021

icddr,b initiated a SARS-CoV-2 variant surveillance in December 2020. The findings warrant continuous monitoring of genetic variations of SARS?CoV?2, which is crucial for vaccine effectiveness and patients management.

05 APRIL 2021

IEDCR and icddr,b conducted a study to investigate the suitability of saliva over the nasopharyngeal swab of suspected COVID-19 patients for detection of SARS-CoV-2.